IndieBio
San Francisco · Seed · 1 people tracked
Investment thesis
Early-stage accelerator for synthetic biology and life sciences that gives scientist-founders lab independence with co-located BSL-rated wet labs and extended runway via SOSV integration reserving 75% for follow-ons.
Team · 1 people
from the firm's website
Po Bronson, a bestselling author turned full‑time deep‑tech biotech investor, applies storytelling and a reporter/social‑scientist approach—running hundreds of interviews to judge founders' motivations and decision‑making under pressure.
Frequently asked questions
- What stage does IndieBio invest at?
- IndieBio invests at the Seed stage.
- What is IndieBio's typical check size?
- IndieBio typically writes checks of $525K.
- What sectors does IndieBio focus on?
- IndieBio focuses on AgTech, Biotech, Climate Tech, FoodTech, Healthtech, New Materials.
- Where is IndieBio located?
- IndieBio is headquartered in San Francisco, US.
- Does IndieBio lead rounds?
- IndieBio typically participates in rounds rather than leading them.
Similar investors
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Snatched Ventures is a venture capital firm that partners with entrepreneurs pursuing bold, transformative visions, offering strategic support to help scale breakthrough innovations.
SOSV is a deep tech venture capital firm that makes first-check pre-seed investments and follow-on rounds in startups focused on human and planetary health, providing lab space and hands-on support at its US locations.
Overwater Ventures is an early-stage venture firm that partners with pre-seed and seed stage founders working on large-scale problems, offering hands-on support across launch strategy, go-to-market, fundraising, and marketing.
Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.